Boston Scientific Gets FDA Approval for the NIR Coronary Stent

FDA has granted approval to Boston Scientific Corp. for the market release of the NIR ON Ranger and the NIR ON Ranger with SOX over-the-wire balloon-expandable premounted coronary stent systems for the treatment of coronary artery disease. The stent will be available in lengths of 9, 16, 25, and 32 mm and diameters of 2.5, 3.0, 3.5, and 4.0 mm.

The patented stent is based on a proprietary transformable geometry design that allows for flexibility during insertion and rigidity after implantation. The patented SOX stent securement system enhances safety in delivering the stent.

The NIR stent was developed and is manufactured by Medinol Ltd. of Tel Aviv, Israel. Boston Scientific has an exclusive worldwide license to market and distribute the NIR stent.